CD274 and non-small cell lung carcinoma: In the present study, the expression of four key immune markers, the checkpoint molecules PD-1 and PD-L1, the antitumor T cell marker CD8 and the immunosuppressive Treg marker FOXP3 and their potential prognostic value in NSCLC were investigated.